Center-Authored Papers

Filters: Keyword is Safety  [Clear All Filters]
1990
Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL et al..  1990.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.. The New England journal of medicine. 323(9):570-8. Abstract
2002
Yee C, Thompson JA, Byrd D, Riddell SR, Roche P, Celis E, Greenberg PD.  2002.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.. Proceedings of the National Academy of Sciences of the United States of America. 99(25):16168-73. Abstract
2008
le Coutre P, Ottmann OG, Giles F, Kim D-W, Cortes J, Gattermann N, Apperley JF, Larson RA, Abruzzese E, O'Brien SG et al..  2008.  Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia.. Blood. 111(4):1834-9. Abstract
Priddy FH, Brown D, Kublin J, Monahan K, Wright DP, Lalezari J, Santiago S, Marmor M, Lally M, Novak RM et al..  2008.  Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 46(11):1769-81. Abstract
Koelle DM, Magaret AS, McClurkan CL, Remington ML, Warren T, Teofilovici F, Wald A.  2008.  Phase I dose-escalation study of a monovalent heat shock protein 70-herpes simplex virus type 2 (HSV-2) peptide-based vaccine designed to prime or boost CD8 T-cell responses in HSV-naïve and HSV-2-infected subjects.. Clinical and vaccine immunology : CVI. 15(5):773-82. Abstract
2009
Strong LL, Starks HE, Meischke H, Thompson B.  2009.  Perspectives of mothers in farmworker households on reducing the take-home pathway of pesticide exposure.. Health education & behavior : the official publication of the Society for Public Health Education. 36(5):915-29. Abstract
Yokoe D, Casper C, Dubberke E, Lee G, Muñoz P, Palmore T, Sepkowitz K, Young J-AH, Donnelly JP.  2009.  Safe living after hematopoietic cell transplantation.. Bone marrow transplantation. 44(8):509-19.
2010
Wundes A, Kraft GH, Bowen JD, Gooley TA, Nash RA.  2010.  Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.. Clinical neurology and neurosurgery. 112(10):876-82. Abstract
Shaw BE, Ball L, Beksac M, Bengtsson M, Confer D, Diler S, Fechter M, Greinix H, Koh M, Lee SJ et al..  2010.  Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.. Bone marrow transplantation. 45(5):832-8. Abstract
2015
Mandell DJ, Lajoie MJ, Mee MT, Takeuchi R, Kuznetsov G, Norville JE, Gregg CJ, Stoddard BL, Church GM.  2015.  Biocontainment of genetically modified organisms by synthetic protein design.. Nature. 518(7537):55-60. Abstract